Lyon: Maintain BUD APAC (01876) "outperform the market" rating, raise target price to HK$10.4.
The statement indicates that the management is pleased to actively expand the market share in China and is more optimistic about its prospects.
Lyon issued a research report stating that it maintains a "outperform" rating on BUD APAC (01876) with a target price raised from 9.1 Hong Kong dollars to 10.4 Hong Kong dollars. The bank predicts that the group's revenue will increase by 5% year-on-year this year, and the pre-tax and interest depreciation and amortization profit will remain flat year-on-year, mainly due to the higher gross profit margin offsetting the higher marketing expenses.
Lyon pointed out that BUD APAC's fourth-quarter revenue fell by 11.7% year-on-year to 1.1 billion US dollars, lower than expected, mainly due to drag in the mainland market. Its organic pre-tax and interest depreciation and amortization profit exceeded expectations, with a net loss of 16 million US dollars, lower than expected.
The bank mentioned that it is pleased to see the management actively expanding its market share in China and is more optimistic about its prospects. Even though some measures are still in the preliminary stage and need to be implemented over time, some positive factors can still be seen, such as accelerating the pace of execution, being more willing to increase marketing expenses, adopting new packaging, more innovation, and a low base, etc.
Related Articles

ST Holdings (08305) issued a profit warning, expecting the comprehensive loss for the year 2025 to increase by no less than 19 million Hong Kong dollars compared to the previous year.

CLOVER BIO-B(02197): Clover Hong Kong has entered into a settlement agreement with the Global Vaccine Immunization Alliance.

NEW GONOW RV (00805) is expected to have a net profit of approximately 31 to 40 million yuan in the fiscal year 2025, a year-on-year decrease of about 12.07% to 31.85%.
ST Holdings (08305) issued a profit warning, expecting the comprehensive loss for the year 2025 to increase by no less than 19 million Hong Kong dollars compared to the previous year.

CLOVER BIO-B(02197): Clover Hong Kong has entered into a settlement agreement with the Global Vaccine Immunization Alliance.

NEW GONOW RV (00805) is expected to have a net profit of approximately 31 to 40 million yuan in the fiscal year 2025, a year-on-year decrease of about 12.07% to 31.85%.

RECOMMEND

State Reform Fund And Three Major Banks Backstop Voyah As It Secures Hong Kong’s First Auto IPO This Year
20/03/2026

Hong Kong IPO Irregularities Surface As Corner Placements And Retail Losses Emerge, Haizhi Technology Implicated
20/03/2026

Gold And Silver Experience Sharp Sell‑Off As Global Rate‑Hike Expectations Intensify
20/03/2026


